Koers Surgical Science Sweden AB (publ) Nasdaq Stockholm
Aandelen
SE0014428512
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 939 mln. 87,62 mln. 80,62 mln. | Omzet 2025 * | 1,16 mld. 108 mln. 99,41 mln. | Marktkapitalisatie | 7,07 mld. 660 mln. 607 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 186 mln. 17,36 mln. 15,97 mln. | Nettowinst (verlies) 2025 * | 287 mln. 26,79 mln. 24,65 mln. | EV/omzet 2024 * | 6,66 x |
Nettoliquiditeiten 2024 * | 818 mln. 76,32 mln. 70,23 mln. | Nettoliquiditeiten 2025 * | 1,1 mld. 103 mln. 94,58 mln. | EV/omzet 2025 * | 5,15 x |
K/w-verhouding 2024 * |
37,8
x | K/w-verhouding 2025 * |
24,6
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 73,33% |
Recentste transcriptie over Surgical Science Sweden AB (publ)
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anders Larsson
FOU | Founder | 51 | 24-07-97 |
Gisli Hennermark
CEO | Chief Executive Officer | 52 | 01-01-15 |
Director of Finance/CFO | 54 | 01-01-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Roland Bengtsson
CHM | Chairman | 69 | 01-01-05 |
Director/Board Member | 57 | 01-01-17 | |
Director/Board Member | 49 | 12-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,22% | 33,98 mld. | |
+21,99% | 8,16 mld. | |
+31,37% | 4,26 mld. | |
-30,15% | 2,65 mld. | |
-19,11% | 1,4 mld. | |
-28,03% | 1,27 mld. | |
-33,21% | 1,16 mld. | |
+13,85% | 1,02 mld. | |
-34,50% | 917 mln. |